ReVision Therapeutics
About:
ReVision Therapeutics, a biopharmaceutical company, develops drugs for the treatment of age-related macular degeneration diseases.
Website: http://www.revisiontherapeutics.com
Description:
ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. Its product includes Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in 2010 and is based in San Diego, California.
Total Funding Amount:
$3.37M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
San Diego, California, United States
Founded Date:
2010-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2011-12-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai